Nogra Pharma announces out-licensing agreement with Torii Pharmaceutical for Japan for New Chemical Entity topical acne treatment

Dublin, Ireland, 26 January 2023, Nogra Pharma today announces officially it has entered into an out-licensing agreement with Torii Pharmaceutical Co., Ltd. (Torii) (TSE:4551), to further develop and commercialise NAC-GED-0507 in Japan for the treatment of acne vulgaris. Read More

Latest Publications

Read all

Publications

Smad7 as a positive regulator of intestinal inflammatory diseases

2023.01.24

Publications

Smad7 Antisense Oligonucleotide in Crohn’s Disease: A Re-Evaluation and Explanation for the Discordant Results of Clinical Trials

2022.12.28

Publications

Smad7 Sustains Stat3 Expression and Signaling in Colon Cancer Cells

2022.10.12

Learn How to Build a Project with Nogra

Nogra Pharma is available to give comprehensive Project presentations, provide additional Project specific details or confidential information and discuss potential collaborations or out-licensing opportunities with interested companies.